Candidiasis Clinical Trials
71 clinical trials for Candidiasis across international registries, including 3 currently recruiting participants. Compare status, phase, eligibility criteria and locations.
- Large Algorithm Setting and Validation Study — RECRUITING
- PTX3-targeted Antifungal Prophylaxis — RECRUITING · NA
- Vaginal Ecosystem and Network in the United States Study — RECRUITING
- A multicenter study to increase
drug safety concerning the usage of systemic antifungal agents in haematology and oncology — OTHER
- Staging Candidiasis in ICU Patients — COMPLETED
- Fluconazole Versus Micafungin in Neonates With Candidiasis — COMPLETED · PHASE2
- Prospective Observational Study on the Incidence of Opportunistic Fungal Infections — COMPLETED
- A Study to Evaluate the Efficacy and Safety of Micafungin Against Invasive Candidiasis or Candidemia — TERMINATED · PHASE4
- Post Marketing Study to Evaluate the Safety and Efficacy of Micafungin Against Fungal Infections Caused by Candida Spp or Aspergillus Spp — TERMINATED · PHASE4
- The Role of Interferon-gamma in Immune Responses to Invasive Candidiasis — COMPLETED
- Fluconazole Versus Micafungin for Candida Bloodstream Infection in Non-Neutropenic Patients — WITHDRAWN · PHASE4
- PHASE 1 SINGLE CENTRE, OPEN-LABELED CLINICAL TRIAL TO EVALUATE THE SAFETY AND TOLERABILITY OF TOPICAL NITRIC OXIDE RELEASING MOUTHWASH (NORM) FOR THE MANAGEMENT OF OROPHARYNGEAL CANDIDIASIS — COMPLETED · PHASE1
- A PHASE 3, MULTICENTER, PROSPECTIVE, RANDOMIZED, DOUBLE-BLIND STUDY OF TWO TREATMENT REGIMENS FOR CANDIDEMIA AND/OR INVASIVE CANDIDIASIS: INTRAVENOUS ECHINOCANDIN FOLLOWED BY ORAL IBREXAFUNGERP VERSUS INTRAVENOUS ECHINOCANDIN FOLLOWED BY ORAL FLUCONAZOLE (MARIO) — COMPLETED · PHASE3
- Investigation of the Relationship Between Salivary Histatine-5 Level and Vaginal Candidiasis in Women — COMPLETED
- A Study to Assess the Effect of Concomitant Administration of Fluconazole on the Clinical Pharmacokinetics of Methadone — COMPLETED · PHASE1
- A Randomized, Prospective, Double-Blind Study Comparing Fluconazole With Placebo for Primary and Secondary Prophylaxis of Mucosal Candidiasis in HIV-Infected Women — COMPLETED · NA
- Randomized Comparative Study of Fluconazole Versus Clotrimazole Troches in the Prevention of Serious Fungal Infection in Patients With AIDS or Advanced AIDS-Related Complex. (A Nested Study of ACTG 081) — COMPLETED · PHASE3
- Fluconazole Pharmacokinetics, Including Bioavailability, in Obese Subjects After an Intravenous and Oral Administration — COMPLETED · PHASE4
- Pharmacokinetics of Fluconazole IV as Prophylaxis or Therapy to ICU Patients — COMPLETED
- Bioavailability of Flucanazole — OTHER · PHASE1
- Effect of Adjuvant & Route of Administration on Safety & Immunogenicity of NDV-3 Vaccine — COMPLETED · PHASE1
- Use of Boric Acid in Combination With Probiotics for the Treatment of Vaginal Infections — COMPLETED · PHASE4
- Early Diagnosis of Candidiasis in Premature Infants — COMPLETED
- Fluconazole Prophylaxis for the Prevention of Candidiasis in Infants Less Than 750 Grams Birthweight — COMPLETED · PHASE3
- Funguria in Hospitalized Patients — COMPLETED
- Pharmacokinetics (PK) Study of a Fluconazole Loading Dose in Infants and Toddlers — COMPLETED · PHASE1
- Study of FK463 in the Treatment of Candidemia or Invasive Candidiasis — COMPLETED · PHASE2
- Efficacy of Anidulafungin in the treatment of invasie candida infections in clinical practice — OTHER
- Clinical and Laboratorial Evaluation of the Desinfection Solutions in Candida Species From Total Prostheses and Palate of Total Edentulous. — COMPLETED · NA
- Candida Host Defense Response After Septic Shock in the Critically Ill — COMPLETED
- Caspofungin for the Treatment of Non-blood Candida Infections (0991-045) — COMPLETED · PHASE2
- Open, Pharmacokinetic Study of Caspofungin in Neonates and Infants (0991-058) — COMPLETED · PHASE2
- Documented Candida or Aspergillus Infections in Pediatric Patients (0991-043) — COMPLETED · PHASE2
- Immunological Interaction Between the Host and Candida Albicans Biofilm — COMPLETED
- Validity of Patient-Collected Wet Mounts — COMPLETED · NA
- A Study Of The Safety, Tolerability And Effective Of Voriconazole For The Treatment Of Serious Candida Infection And Candida Infection Of The Throat In Pediatric Patients — TERMINATED · PHASE3
- A Clinical Study to Evaluate the Pharmacokinetics of Lozanoc and Sporanox in Korean Healthy Male Volunteers — COMPLETED · PHASE1
- Study to Compare the Efficacy and Safety of Micafungin Versus Conventional Amphotericin B for the Treatment of Neonatal Candidiasis — TERMINATED · PHASE3
- Effect of Probiotic Bacteria on Oral Candida in Frail Elderly — COMPLETED · NA
- Incidence of Oral Candidiasis, Prevalence of C. Dubliniensis in HIV Patients and In-vitro Azole Susceptibility — TERMINATED
- Caspofungin Study for Fungal Infections in Adults in Critical Care Settings — TERMINATED · PHASE3
- Topical Metronidazole and Miconazole Co-formulated Vaginal Suppositories for Preventing Vaginal Infections in HIV-seronegative Women — COMPLETED · PHASE2
- Study of Micafungin in Patients With Invasive Candidiasis or Candidemia — COMPLETED · PHASE3
- Micafungin Versus AmBisome in Invasive Candidiasis and Candidemia — COMPLETED · PHASE3
- Early Clinical Experience With Anidulafungin In Patients With Liver Disease In The United Kingdom — COMPLETED
- An Evaluation Of The Effectiveness And Safety Of Anidulafungin Compared To Caspofungin For The Treatment Of Deep Tissue Infection Due To Candida — TERMINATED · PHASE3
- A Pharmacokinetic Study of JK1211(Itraconazole [Itrizole]) Oral Solution in Participants With Deep Mycosis and Those With Febrile Neutropenia Suspected of Fungal Infection — COMPLETED · PHASE3
- An Evaluation Of The Effectiveness And Safety Of Anidulafungin Compared To Caspofungin For The Treatment Of Serious Fungal Infection Due To Candida In Patients With A Dysfunctional Immune System — TERMINATED · PHASE3
- Efficacy and Safety of LAS41003 in the Treatment of Intertriginous Candida Infections — COMPLETED · PHASE2
- Safety and Immunogenicity Study of a Recombinant Protein Vaccine (NDV-3) Against S.Aureus and Candida — COMPLETED · PHASE1
Refine this search